Analogously, RPN2 knockdown induced docetaxel-dependent apoptosis and cell growth inhibition in human breast cancer cells by reducing glycosylation of the P-glycoprotein with N-linked glycosylation, as well as decreasing membrane localization [12]. This evidence concerns the gene RPN2 and breast cancer.